コンテンツへスキップ
Merck
  • A myasthenic syndrome with congenital paucity of secondary synaptic clefts: CPSC syndrome.

A myasthenic syndrome with congenital paucity of secondary synaptic clefts: CPSC syndrome.

Muscle & nerve (1988-04-01)
L M Smit, G Hageman, H Veldman, P C Molenaar, B S Oen, F G Jennekens
要旨

Two cases of a newly recognized myasthenic syndrome were investigated (CPSC syndrome). The course of the disease was observed for periods of 6 and 3 years. In infancy, exacerbations of the symptoms occurred during febrile illness, but thereafter the clinical course was stable and the children appeared to be only slightly handicapped. Biopsies were taken from the intercostal muscle in both patients. Microelectrode studies revealed small Mepp amplitudes. Light microscopy demonstrated predominance of type I fibers and focal type-grouping. There was a lowered cholinesterase activity and frequent branching of preterminal axons. Electron microscopy revealed that there were few, if any, folds of the postsynaptic membrane and that there were no signs of degeneration. Methods for localization of acetylcholine receptors (AChR) revealed a deficiency and altered distribution of AChRs at these postsynaptic membranes and the occurrence of extrajunctional AChRs in some muscle fibers. It is concluded that the syndrome is a clinicopathological entity, characterized morphologically by a congenital paucity of secondary synaptic clefts (CPSC syndrome).

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ムチン ブタ胃由来, Type III, bound sialic acid 0.5-1.5 %, partially purified powder
Sigma-Aldrich
ムチン ブタ胃由来, Type II